New Weight-Loss injection under study: will it work the same?
NCT ID NCT07382908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two versions of an experimental injection called BGM0504 to see if they work the same way in the body. It involves 144 overweight or obese adults aged 18-55. Participants receive a single dose, and researchers measure drug levels and monitor for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hangzhou First People's Hospital
RECRUITINGHangzhou, Zhejiang, 310006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can patients power their own obesity research?
- Can antioxidant pills boost skin and blood carotenoids to improve cardiometabolic health?
- Could a daily probiotic help you feel fuller and eat less?
- Heart safety check for new Weight-Loss drug candidate
- Fasting plus fibre: a Gut-Boosting combo?
- AI health coach gives Real-Time weight loss tips via smartphone